TG Therapeutics, Inc (TGTX) insider trading
Every open-market stock purchase and sale by TG Therapeutics, Inc executives, directors, large shareholders and members of Congress, from SEC Form 4 filings. Sector: Other.
Insider activity at a glance
- Insiders sold $163K over the last 12 months (1 sale). No open-market buys.
- Last insider buy: Michael S Weiss (CEO), $1M, 3 years ago.
Last 12 months: insiders bought $0 (0 buys) and sold $163K (1 sale). Last close $40.95 on Jun 7, 2026.
Recent TGTX insider trades
| Date | Insider | Trade | Value |
|---|---|---|---|
| Jun 11, 2026 | Kenneth Hoberman (Director) | Bought (not open market) | — |
| Jun 11, 2026 | Laurence N Charney (Director) | Bought (not open market) | — |
| Jun 11, 2026 | Yann Echelard (Director) | Bought (not open market) | — |
| Jun 11, 2026 | Daniel Hume (Director) | Bought (not open market) | — |
| Jun 11, 2026 | Sagar Lonial (Director) | Bought (not open market) | — |
| Jan 29, 2026 | Laurence N Charney (Director) | Sold (not open market) | — |
| Jan 28, 2026 | Laurence N Charney (Director) | Sold (not open market) | — |
| Jan 8, 2026 | Sean A Power (CFO) | Bought (not open market) | — |
| Jan 8, 2026 | Michael S Weiss (CEO) | Bought (not open market) | — |
| Nov 24, 2025 | Yann Echelard (Director) | Sold | $163K |
| Nov 5, 2025 | Michael S Weiss (CEO) | Sold (not open market) | — |
| Nov 5, 2025 | Michael S Weiss (CEO) | Sold (not open market) | — |
Who's trading TGTX
- Laurence N Charney, Director: other filings, last Jun 11, 2026
- Yann Echelard, Director: sold $163K (1 sale), last Jun 11, 2026
- Daniel Hume, Director: other filings, last Jun 11, 2026
- Kenneth Hoberman, Director: other filings, last Jun 11, 2026
- Sagar Lonial, Director: other filings, last Jun 11, 2026
- Sean A Power, CFO: other filings, last Jan 8, 2026
- Michael S Weiss, CEO: other filings, last Jan 8, 2026
Get free alerts when an insider at TG Therapeutics, Inc files a new trade →